First GLP-1 pill for obesity from Novo Nordisk launches in the U.S.
The logo of pharmaceutical company Novo Nordisk is displayed in front of its offices in Bagsvaerd, on the…
Endonuclease V activated Pyrococcus furiosus Argonaute for the detection of food contaminated bacteria
Banada, P. P. et al. Label-free detection of multiple bacterial pathogens using light-scattering sensor. Biosens. Bioelectron. 24, 1685–1692…
U.S. vaccine policy could see big changes in 2026
WASHINGTON — Vaccine policy has become a key issue for the Trump administration, especially under the leadership of…
Blocking platelet-activating factor reduces liver damage in cirrhosis
Researchers from Miguel Hernández University of Elche (UMH) in Spain have identified an effective strategy to reduce structural…
FDA voucher program has led to political interference in drug reviews, staffers say
WASHINGTON — A new program intended to fast-track drug reviews at the Food and Drug Administration is quickly…
Commission proposes new measures to improve health and the healthcare sector
The European Commission has put forward a raft of new measures that will improve the health of Europeans…
Eli Lilly’s weight loss drug retatrutide clears first late-stage study
The Eli Lilly logo appears on the company’s office in San Diego, California, U.S., Nov. 21, 2025. Mike…
Avant Technologies and Austrianova Advancing α-Klotho Cell Therapy as Mayo Clinic Study Links Low α-Klotho Levels to Poor Cardiovascular Survival
LAS VEGAS, Dec. 9, 2025 /PRNewswire/ — Avant Technologies, Inc. (OTCQB: AVAI)Â (“Avant” or the “Company”), an emerging biotechnology…
Generative AI aids discovery of ISM3830’s novel scaffold
Casitas B-lineage lymphoma-b (CBLB) is an E3 ubiquitin–protein ligase that functions as an intracellular checkpoint and master negative…
Contributors to top psychiatry journals fail to disclose industry payments
Amid ongoing concern over conflicts of interest that may affect medical practice, a new study found that 14%…
Epigenetic drift explains why the aging intestine becomes more vulnerable to cancer
Researchers from the Leibniz Institute on Aging – Fritz Lipmann Institute (FLI) in Jena, Germany, the Molecular Biotechnology…
FDA reviewers didn’t get to vote on first priority voucher drug
WASHINGTON — The Food and Drug Administration has promised companies that earn a Commissioner’s National Priority Voucher a one-…